Human breast tumours were analyzed with polymorphic microsatellite markers specific to chromosome 3p. Allelic imbalance (AI) was observed in 34% of the tumours. Microsatellite markers from two regions showed higher percentage of imbalance suggesting the presence of tumour suppressor genes or genes important for malignancy. Microsatellite instability was also found, implying errors in DNA replication. No significant correlation was found between AI and conventional prognostic variables. However, a striking correlation was found between AI and tumour S-phase fraction; AI was also significantly correlated with low steroid receptor content. A multivariate model including prognostic variables, showed that AI was without exception a significant p...
Loss of heterozygosity (LOH) and allelic imbalance (AI) at loci reported to show allele loss and/or ...
Several chromosome regions exhibit loss of heterozygosity (LOH) in human breast carcinoma and are th...
We examined DNA from 116 female and four male breast cancer patients for loss of heterozygosity (LOH...
Eight Icelandic breast cancer kindreds were subjected to linkage analyses with respect to 28 microsa...
Our previous studies have indicated that genetic aberrations in the 3p14 region are more frequent in...
The loss of genetic material from a specific chromosome region in tumors suggests the presence of tu...
Several chromosome regions exhibit loss of heterozygosity (LOH) in human breast carcinoma and are th...
In this study 238 human primary breast cancers were analysed with 9 polymorphic microsatellite marke...
232 human primary invasive breast tumors were analyzed with 13 polymorphic microsatellite markers sp...
Primary breast tumors were tested for loss of heterozygosity (LOH), on chromosome 9p with microsatel...
Breast cancer is a heterogeneous disease and patients with similar pathologies and treatments may ha...
PURPOSE: Microsatellite instability in patients with defects in the mismatch repair system resulting...
The analysis of loss of heterozygosity (LOH) in tumours can be used to map candidate sites of tumour...
BACKGROUND: Breast cancer is a heterogeneous disease and patients with similar pathologies and treat...
The loss of genetic material from a specific chromosome region in tumors suggests that presence of t...
Loss of heterozygosity (LOH) and allelic imbalance (AI) at loci reported to show allele loss and/or ...
Several chromosome regions exhibit loss of heterozygosity (LOH) in human breast carcinoma and are th...
We examined DNA from 116 female and four male breast cancer patients for loss of heterozygosity (LOH...
Eight Icelandic breast cancer kindreds were subjected to linkage analyses with respect to 28 microsa...
Our previous studies have indicated that genetic aberrations in the 3p14 region are more frequent in...
The loss of genetic material from a specific chromosome region in tumors suggests the presence of tu...
Several chromosome regions exhibit loss of heterozygosity (LOH) in human breast carcinoma and are th...
In this study 238 human primary breast cancers were analysed with 9 polymorphic microsatellite marke...
232 human primary invasive breast tumors were analyzed with 13 polymorphic microsatellite markers sp...
Primary breast tumors were tested for loss of heterozygosity (LOH), on chromosome 9p with microsatel...
Breast cancer is a heterogeneous disease and patients with similar pathologies and treatments may ha...
PURPOSE: Microsatellite instability in patients with defects in the mismatch repair system resulting...
The analysis of loss of heterozygosity (LOH) in tumours can be used to map candidate sites of tumour...
BACKGROUND: Breast cancer is a heterogeneous disease and patients with similar pathologies and treat...
The loss of genetic material from a specific chromosome region in tumors suggests that presence of t...
Loss of heterozygosity (LOH) and allelic imbalance (AI) at loci reported to show allele loss and/or ...
Several chromosome regions exhibit loss of heterozygosity (LOH) in human breast carcinoma and are th...
We examined DNA from 116 female and four male breast cancer patients for loss of heterozygosity (LOH...